Abstract
A 48‐year‐old man became erythrodermatous after intramuscular administration of ribostamycin, an aminoglycoside antibiotic in the same family as neomycin. Patch tests were positive to ribostamycin and neomycin, as well as to mercurials. There was no mercurial preservative in the injection solution. A lymphocyte transformation test was positive for ribostamycin and tobramycin, but not for gentamycin. Diagnostic and structure‐activity relationship aspects of the case are discussed. Copyright © 1989, Wiley Blackwell. All rights reserved
| Original language | English |
|---|---|
| Pages (from-to) | 79-82 |
| Journal | Contact Dermatitis |
| Volume | 21 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 1 Jan 1989 |
Keywords
- adverse effects
- aminoglycosides
- antibiotics
- cross‐sensitization
- drug eruption
- lymphocyte transformation test
- medicaments
- neomycin
- patch tests
- ribostamycin